Frontiers in oncology

publication venue for

Case Report: First report of a Wilms tumor in an individual with Dias-Logan syndrome (BCL11A-related intellectual disability). 2025
Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis. 2024
Case report: Isolated axillary lymph node metastasis in high-risk endometrial cancer. 2024
Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis. 2024
Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report. 2024
Polymorphous low-grade neuroepithelial tumor of the young with FGFR3-TACC3 fusion mimicking high-grade glioma: case report and series of high-grade correlates. 2023
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report. 2022
Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma. 2021
Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity. 2021
Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab. 2020
A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Reported in ALL. 2019
hNIS-based imaging to monitor treatment with the novel oncolytic virus CF33-hNIS-antiPDL1 in humans with advanced triple negative breast cancer.. 15. 2025
Repurposing riluzole as an anti-osteosarcoma agent.. 15. 2025
Initial clinical experience with [¹⁷⁷Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial.. 14. 2025
A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.. 14. 2024
The intersection of the HER2-low subtype with endocrine resistance: the role of interconnected signaling pathways.. 14. 2024
Aronia melanocarpa L. fruit peels show anti-cancer effects in preclinical models of breast carcinoma: The perspectives in the chemoprevention and therapy modulation.. 14. 2024
Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model.. 14. 2024
The prognostic and predictive value of homologous recombination deficiency status in patients with advanced stage epithelial ovarian carcinoma after first-line platinum-based chemotherapy.. 14. 2024
Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older.. 14. 2024
Nanocage-incorporated engineered destabilized 3'UTR ARE of ERBB2 inhibits tumor growth and liver and lung metastasis in EGFR T790M osimertinib- and trastuzumab-resistant and ERBB2-expressing NSCLC via the reduction of ERBB2.. 14. 2024
Associations of reproductive breast cancer risk factors with expression of stem cell markers in benign breast tissue.. 14. 2024
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice.. 14. 2024
Artificial intelligence in liver cancer research: a scientometrics analysis of trends and topics.. 14. 2024
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial.. 13. 2024
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.. 13. 2023
Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer.. 13. 2023
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer.. 13. 2023
Concurrent chemotherapy with partial breast irradiation in triple negative breast cancer patients may improve disease control compared with sequential therapy.. 13. 2023
Predicting cancer relapse following lung stereotactic radiotherapy: an external validation study using real-world evidence.. 13. 2023
A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma.. 13. 2023
Interactive process mining of cancer treatment sequences with melanoma real-world data.. 13. 2023
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients.. 13. 2023
Geographic variation in malignant cardiac tumors and their outcomes: SEER database analysis.. 13. 2023
The underexplored links between cancer and the internal body climate: Implications for cancer prevention and treatment.. 12. 2022
Detection of circulating KRAS mutant DNA in extracellular vesicles using droplet digital PCR in patients with colon cancer.. 12. 2022
A differential process mining analysis of COVID-19 management for cancer patients.. 12. 2022
Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations.. 12. 2022
The initial experience of MRI-guided precision prone breast irradiation with daily adaptive planning in treating early stage breast cancer patients.. 12. 2022
Use of multimodality imaging, histology, and treatment feasibility to characterize a transgenic Rag2-null rat model of glioblastoma.. 12. 2022
Automated lesion detection of breast cancer in [¹⁸F] FDG PET/CT using a novel AI-Based workflow.. 12. 2022
Quality of life and function after rectal cancer surgery with and without sphincter preservation.. 12. 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).. 12. 2022
Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases.. 12. 2022
The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy.. 12. 2022
A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery.. 12. 2022
PET Imaging of Acidic Tumor Environment With ⁸⁹Zr-labeled pHLIP Probes.. 12. 2022
Preoperative Thyroid Peroxidase Antibody Predicts Recurrence in Papillary Thyroid Carcinoma: A Consecutive Study With 5,770 Cases.. 12. 2022
Machine Learning Models for Classifying High- and Low-Grade Gliomas: A Systematic Review and Quality of Reporting Analysis.. 12. 2022
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1 ^low Mice.. 12. 2022
All-Trans-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism.. 12. 2022
PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: Implications for Pathophysiology and Tumor Outcomes.. 11. 2022
Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study.. 11. 2022
Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma.. 11. 2021
Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer.. 11. 2021
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients.. 11. 2021
Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice.. 11. 2021
Antidiabetic DPP-4 Inhibitors Reprogram Tumor Microenvironment That Facilitates Murine Breast Cancer Metastasis Through Interaction With Cancer Cells via a ROS-NF-кB-NLRP3 Axis.. 11. 2021
A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.. 11. 2021
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML.. 11. 2021
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma.. 11. 2021
Early Cumulative Fluid Balance and Outcomes in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients With Acute Respiratory Failure: A Multicenter Study.. 11. 2021
G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Mantle Cell Lymphoma Growth in Preclinical Models.. 11. 2021
Antidiabetic Agent DPP-4i Facilitates Murine Breast Cancer Metastasis by Oncogenic ROS-NRF2-HO-1 Axis via a Positive NRF2-HO-1 Feedback Loop.. 11. 2021
Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.. 11. 2021
Changes in Urologic Operative Practice at the Beginning of the COVID-19 Pandemic in a Large, National Cohort.. 11. 2021
The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm.. 11. 2021
Delirium in Children Undergoing Hematopoietic Cell Transplantation: A Multi-Institutional Point Prevalence Study.. 11. 2021
Challenges in Diversity, Equity, and Inclusion in Research and Clinical Oncology.. 11. 2021
Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation.. 11. 2021
Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer.. 11. 2021
In Memory of Professor John Gordon McVie: Bringing People Together 13 January 1945 - 20 January 2021.. 11. 2021
Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer.. 11. 2021
Comparison Between Urothelial and Non-Urothelial Urethral Cancer.. 10. 2021
The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer.. 10. 2021
Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection.. 10. 2020
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort.. 10. 2020
Human Endogenous Retrovirus Expression Is Upregulated in the Breast Cancer Microenvironment of HIV Infected Women: A Pilot Study.. 10. 2020
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort.. 10. 2020
Apoptosis in Cancer Cells Is Induced by Alternative Splicing of hnRNPA2/B1 Through Splicing of Bcl-x, a Mechanism that Can Be Stimulated by an Extract of the South African Medicinal Plant, Cotyledon orbiculata.. 10. 2020
CAR Chase: Where Do Engineered Cells Go in Humans?. 10. 2020
Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin.. 10. 2020
Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse Model.. 10. 2020
Registering Study Analysis Plans (SAPs) Before Dissecting Your Data-Updating and Standardizing Outcome Modeling.. 10. 2020
Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity.. 10. 2020
Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer.. 10. 2020
Anterior Clinoidal Meningiomas: Meningeal Anatomical Considerations and Surgical Implications.. 10. 2020
Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach.. 10. 2020
Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.. 9. 2019
Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models.. 9. 2019
Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells.. 9. 2019
Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis.. 9. 2019
Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy.. 9. 2019
Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.. 8. 2018
Alcohol and Tobacco Use in an Ethnically Diverse Sample of Breast Cancer Patients, Including Sea Island African Americans: Implications for Survivorship.. 8. 2018
Single Stage Transoral Laser Microsurgery for Early Glottic Cancer.. 8. 2018
A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer.. 8. 2018
MYC Immunohistochemistry Predicts MYC Rearrangements by FISH.. 7. 2017
Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy.. 7. 2017
Evaluating Post-Radiotherapy Laryngeal Function with Laryngeal Videostroboscopy in Early Stage Glottic Cancer.. 7. 2017
Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure.. 6. 2016
(13)C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism.. 6. 2016
Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer.. 5. 2015
Novel Treatments for Thymoma and Thymic Carcinoma.. 5. 2015
Use of a Flexible Inflatable Multi-Channel Applicator for Vaginal Brachytherapy in the Management of Gynecologic Cancer.. 5. 2015
Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States.. 5. 2015
P62/Ubiquitin IHC Expression Correlated with Clinicopathologic Parameters and Outcome in Gastrointestinal Carcinomas.. 5. 2015
MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens.. 5. 2015
Prom1 function in development, intestinal inflammation, and intestinal tumorigenesis.. 4. 2014
Toxicity and disease-related outcomes after radiotherapy for head and neck cancer in human immunodeficiency virus-positive patients.. 4. 2014
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.. 4. 2014
Development of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer.. 4. 2014
Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year study.. 4. 2014
Sequential administration of carbon nanotubes and near-infrared radiation for the treatment of gliomas.. 4. 2014
Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancer.. 3. 2013
Quality of life following amputation or limb preservation in patients with lower extremity bone sarcoma.. 3. 2013
Additive Influence of Extracellular pH, Oxygen Tension, and Pressure on Invasiveness and Survival of Human Osteosarcoma Cells.. 3. 2013
Radiotherapy effects on anti-tumor immunity: implications for cancer treatment.. 3. 2013
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.. 3. 2013
Is there a role for an external beam boost in cervical cancer radiotherapy?. 3. 2013
Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer.. 2. 2013
An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors.. 2. 2012
Radiation as an immunological adjuvant: current evidence on dose and fractionation.. 2. 2012
Isolation and characterization of circulating tumor cells in prostate cancer.. 2. 2012
Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity.. 2. 2012
Do circulating tumor cells play a role in coagulation and thrombosis?. 2. 2012
Role of T lymphocytes in tumor response to radiotherapy.. 2. 2012
Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomide.. 2. 2012
The convergence of radiation and immunogenic cell death signaling pathways.. 2. 2012
Comparison of Acute and Late Toxicity of Two Regimens of 3- and 5-Week Concomitant Boost Prone IMRT to Standard 6-Week Breast Radiotherapy.. 2. 2012
Pathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease.. 2. 2012
The role of a prone setup in breast radiation therapy.. 1. 2011
Grand challenges in oncology.. 1. 2011
Challenges in cancer molecular targets and therapeutics.. 1. 2011
Editorial: Advancements in drug development: exploring bi-specific antibodies as promising therapeutic strategies in oncology.. 15. 2025
Editorial: Measurable residual disease in hematologic malignancies.. 13. 2023
Editorial: Prognostic factors in non-small cell lung cancer.. 13. 2023
Editorial: Molecular genetics and therapeutic advances in renal carcinoma.. 12. 2023
Editorial: Advances in the Diagnosis and Treatment of Skull Base Tumours.. 12. 2022
Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy.. 10. 2020
Editorial: EBV-Associated Carcinomas: Presence, Role, and Prevention Strategies.. 8. 2018
Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer. 2021
Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma. 2021
Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis. 2021
Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors. 2019
Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies. 2015
Combinations of immunotherapy and radiation in cancer therapy. 2014
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer. 2025
Tumor-microenvironment and molecular biology of classic Hodgkin lymphoma in children, adolescents, and young adults. 2025
Robotic-assisted lung nodule diagnosis and resection. 2025
Long-read sequencing for brain tumors. 2024
Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials. 2023
Weaving the nest: extracellular matrix roles in pre-metastatic niche formation. 2023
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies. 2023
A review of research on the intersection between breast cancer and cardiovascular research in the Women's Health Initiative (WHI). 2023
Tyrosine kinases in nodal peripheral T-cell lymphomas. 2023
MRI-LINAC: A transformative technology in radiation oncology. 2023
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer. 2023
The potential impact of melanosomal pH and metabolism on melanoma. 2022
Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance. 2022
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment. 2022
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer. 2022
Treatment of Retinoblastoma: What Is the Latest and What Is the Future. 2022
Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor. 2021
A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression. 2021
Platelets and Metastasis: New Implications of an Old Interplay. 2020
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future. 2020
Targeted Therapies and Biomarkers in Small Cell Lung Cancer. 2020
Artificial Intelligence in the Management of Glioma: Era of Personalized Medicine. 2019
Metadherin: A Therapeutic Target in Multiple Cancers. 2019
Machine Learning and Radiogenomics: Lessons Learned and Future Directions. 2018
Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway. 2018
Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer. 2018
Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era. 2017
Ghrelin and Breast Cancer: Emerging Roles in Obesity, Estrogen Regulation, and Cancer. 2017
Disparities in Gynecological Malignancies. 2016
Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy. 2015
Immunotherapy of Childhood Sarcomas. 2015
Targeting neuroendocrine prostate cancer: molecular and clinical perspectives. 2015
Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia. 2015
CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic. 2015
The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries. 2014
The many faces of neuroendocrine differentiation in prostate cancer progression. 2014
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy. 2013

VIVO Weill Cornell Medical College

Frontiers in oncology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)